logo-loader

Precipio Inc shares surge on Clearbridge Health deal news

Last updated: 14:56 05 Jul 2017 EDT, First published: 09:56 05 Jul 2017 EDT

shutterstock_578045545_595d36ea39467
"We are looking forward to working with the team at Precipio to bring the highest level of care to patients within our network."

Shares in Precipio Inc (NASDAQ:PRPO) added over 65% to $20.07 on Wednesday after announcing a  multi-country agrement with Clearbridge Health before the bell.

It is to provide the firm's ICE COLD-PCR (ICP) technology in CBH's network of laboratories, serving patients in more than a dozen countries throughout Asia, including China, India, Taiwan, South Korea, Singapore, Malaysia, Indonesia, and Australia.

The deal is expected to significantly increase Precipio's footprint in the Asian market.

Jeremy Yee, chief executive at Clearbridge Health, said: "Precipio's platform of advanced technologies and specialized expertise and diagnostics will be well received by our network of physicians and patients, who are eager to gain access to these important tools.

"We are looking forward to working with the team at Precipio to bring the highest level of care to patients within our network."

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 17 minutes ago